Home›Companies›Biotech & Pharma›Cleveland Diagnostics

Cleveland Diagnostics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 20, 2025·Suggest an edit

About Cleveland Diagnostics

Cleveland Diagnostics is a private company based in Cleveland, Ohio. It has reported $73,336,539 raised in five offerings on Form D since March 2015. Its chief executive is Arnon Chait.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 7, 2025Oct 20, 2025$14,421,653fully sold7$2.0MEquityRule 506(b)Form D ↗
Jan 16, 2024Jan 31, 2024$56,494,419fully sold26$2.1MEquityRule 506(b)Form D ↗
Nov 27, 2017Dec 13, 2017$0of $4.2M target9$0Equity, DebtRule 506(b)Form D ↗
Nov 16, 2016Nov 23, 2016$440,467of $1.0M target5$88,093Equity, DebtRule 506(b)Form D ↗
Mar 3, 2015Mar 20, 2015$1,980,000fully sold8$247KEquityRule 506(b)Form D ↗
Total, five offerings$73,336,539

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cleveland Diagnostics's Form D filed Oct 20, 2025.

NJ
Noel Jee
Director
JR
Joseph Rich
Director
AS
Andrew Summers
Executive officer
SR
AC
Arnon Chait
Chief Executive Officer and director
DW
Dara Wright
Director

Earlier filings also listed Tim Longville (director, last listed Dec 2017), Levi Kushnir (director, last listed Dec 2017), Eli Arad (director, last listed Dec 2017), Ben Bronstein (director, last listed Dec 2017), Karen Shanahan (secretary, last listed Mar 2015), Jeffrey Marshall (director, last listed Mar 2015) and Ilan Goldstein (director, last listed Mar 2015).

Sources

  1. SECCleveland Diagnostics, Inc. filing history